Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Edgar Engleman


  • Large Shareholder, Director at Soleno Therapeutics Inc (SLNO), 2018-02-08
  • Large Shareholder, Director at Eiger Biopharmaceuticals Inc. (EIGR), 2017-04-13
  • Director at Regenxbio Inc. (RGNX), 2015-09-22
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SLNO $1.84 12,592 Large Shareholder, Director 4,033,540 2017-12-15 Filing
SLNO $1.84 1,072,888 Large Shareholder, Director 4,020,948 2017-12-15 Filing
CAPN $0.96 16,303 Large Shareholder, Director 14,638,722 2017-03-07 Filing
CAPN $0.00 902 Large Shareholder, Director 14,622,419 2017-03-07 Filing
CAPN $0.96 1,394,158 Large Shareholder, Director 14,554,583 2017-03-07 Filing